Gilead Sciences Inc (NASDAQ: GILD)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 12/31/2020
Closing price: 58.26
|Support price level:||N/A|
|Resistance price level:||$59.13|
|Relative strength index (14-day RSI)||34.5|
- GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
- GILD is one of this month's worst performers with a return of -4.7%, underperforming 90 percent of stocks in the S&P-100.
- The price of this low-beta stock is expected to increase by 0.39% for every 1% increase in the S&P-500.
- Volatility is forecast to rise over the next month.
- Price broke below prior support level - a short-term bearish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 5.8% in the next week.
- 15.2% in the next month.
- 61.2% in the next year.